Anika Therapeutics, Inc. (ANIK)
ANIK Stock Price Chart
Explore Anika Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze ANIK price movements and trends.
ANIK Company Profile
Discover essential business fundamentals and corporate details for Anika Therapeutics, Inc. (ANIK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
3 May 1993
Employees
288.00
CEO
Stephen D. Griffin
Description
Anika Therapeutics, Inc. is a company dedicated to joint preservation, innovating and providing early intervention orthopedic care across the globe, including the United States and Europe. Their core focus areas include osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and advanced bone-preserving joint technologies. All of Anika's products are developed, manufactured, and commercialized utilizing their proprietary hyaluronic acid (HA) technology platform. Their comprehensive product lines feature an OA pain management family, which includes established treatments like Monovisc, Orthovisc, Cingal, and Hyvisc, all designed to alleviate discomfort from osteoarthritis. The company's joint preservation and restoration offerings are extensive, comprising approximately 150 bone-sparing joint technology products, alongside solutions for sports medicine soft tissue repair and orthopedic regenerative therapies. Furthermore, Anika leverages its HA expertise in a non-orthopedic product family, developing applications such as adhesion barriers, advanced wound care products, ophthalmic solutions, and ear, nose, and throat treatments. Anika Therapeutics, Inc. was established in 1983 and is based in Bedford, Massachusetts.
ANIK Financial Timeline
Browse a chronological timeline of Anika Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 29 Jul 2026
EPS estimate is $0.03, while revenue estimate is $29.21m.
Earnings released on 29 Apr 2026
EPS came in at $0.27 surpassing the estimated -$0.07 by +485.71%, while revenue for the quarter reached $29.61m , beating expectations by +5.22%.
Earnings released on 26 Feb 2026
EPS came in at $0.31 surpassing the estimated -$0.13 by +348.00%, while revenue for the quarter reached $30.62m , beating expectations by +6.03%.
Earnings released on 5 Nov 2025
EPS came in at $0.04 surpassing the estimated $0.02 by +100.00%, while revenue for the quarter reached $27.82m , beating expectations by +0.06%.
Earnings released on 30 Jul 2025
EPS came in at -$0.13 matching the estimated -$0.13, while revenue for the quarter reached $28.22m , beating expectations by +2.49%.
Earnings released on 9 May 2025
EPS came in at -$0.06 falling short of the estimated $0.09 by -166.67%, while revenue for the quarter reached $26.17m , missing expectations by -6.76%.
Earnings released on 12 Mar 2025
EPS came in at -$0.03 falling short of the estimated -$0.01 by -200.00%, while revenue for the quarter reached -$1.29m , missing expectations by -104.59%.
Earnings released on 31 Oct 2024
EPS came in at -$0.25 falling short of the estimated $0.30 by -183.33%, while revenue for the quarter reached $38.75m , beating expectations by +33.63%.
Earnings released on 8 Aug 2024
EPS came in at $0.17 falling short of the estimated $0.23 by -26.09%, while revenue for the quarter reached $41.92m , missing expectations by -0.43%.
Earnings released on 8 May 2024
EPS came in at -$0.31 falling short of the estimated -$0.19 by -63.16%, while revenue for the quarter reached $40.52m , beating expectations by +3.35%.
Earnings released on 13 Mar 2024
EPS came in at -$4.30 falling short of the estimated -$0.26 by -1.55k%, while revenue for the quarter reached $42.97m , beating expectations by +3.79%.
Earnings released on 2 Nov 2023
EPS came in at -$0.45 falling short of the estimated -$0.33 by -36.36%, while revenue for the quarter reached $41.47m , beating expectations by +0.16%.
Earnings released on 8 Aug 2023
EPS came in at -$0.19 surpassing the estimated -$0.34 by +44.12%, while revenue for the quarter reached $44.30m , beating expectations by +9.23%.
Earnings released on 9 May 2023
EPS came in at -$0.71 falling short of the estimated -$0.36 by -97.22%, while revenue for the quarter reached $37.92m , beating expectations by +1.73%.
Earnings released on 6 Mar 2023
EPS came in at -$0.34 falling short of the estimated -$0.22 by -54.55%, while revenue for the quarter reached $39.62m , beating expectations by +5.08%.
Earnings released on 8 Nov 2022
EPS came in at -$0.29 falling short of the estimated -$0.24 by -20.83%, while revenue for the quarter reached $40.26m , beating expectations by +7.12%.
Earnings released on 3 Aug 2022
EPS came in at -$0.20 surpassing the estimated -$0.26 by +23.08%, while revenue for the quarter reached $39.66m , beating expectations by +4.77%.
Earnings released on 5 May 2022
EPS came in at -$0.20 surpassing the estimated -$0.31 by +35.48%, while revenue for the quarter reached $36.69m , beating expectations by +11.41%.
Earnings released on 8 Mar 2022
EPS came in at -$0.40 falling short of the estimated -$0.25 by -60.00%, while revenue for the quarter reached $35.82m , beating expectations by +11.76%.
Earnings released on 4 Nov 2021
EPS came in at $0.04 surpassing the estimated -$0.21 by +119.05%, while revenue for the quarter reached $39.54m , beating expectations by +7.87%.
Earnings released on 5 Aug 2021
EPS came in at $0.45 surpassing the estimated -$0.15 by +400.00%, while revenue for the quarter reached $38.15m , beating expectations by +7.74%.
ANIK Stock Performance
Access detailed ANIK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
